Denmark’s Genmab A/S is in advanced talks to acquire Merus NV, a Dutch drugmaker that’s developing a treatment for cancer of the head and neck, according to people with knowledge of the matter.
Merus has received takeover offers in recent weeks from large drug companies and could announce a deal within days, the people said, asking not to be identified because the matter is private.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.